Skip to main content
Erschienen in: Journal of General Internal Medicine 9/2017

01.05.2017 | Original Research

The Impact of Medication-Based Risk Adjustment on the Association Between Veteran Health Outcomes and Dual Health System Use

verfasst von: Thomas R. Radomski, MD, MS, Xinhua Zhao, PhD, Carolyn T. Thorpe, PhD, MPH, Joshua M. Thorpe, PhD, MPH, Jennifer G. Naples, PharmD, Maria K. Mor, PhD, Chester B. Good, MD, MPH, Michael J. Fine, MD, MSc, Walid F. Gellad, MD, MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Veterans commonly receive care from both Veterans Health Administration (VA) and non-VA sources (i.e., dual use). A major challenge in comparing health outcomes between dual users and VA-predominant users is applying an accurate method of risk adjustment.

Objective

To determine how different comorbidity indices affect the association between patterns of dual use and health outcomes.

Design

Retrospective cohort.

Participants

A total of 316,775 community-dwelling Veterans (≥65 years) with type 2 diabetes who were enrolled in VA and fee-for-service Medicare from 2008 to 2010.

Methods

We determined the associations between dual use and death or diabetes-related hospitalization in FY 2010 using multivariable models incorporating claims-based (Elixhauser) or medication-based (RxRisk-V) risk adjustment. Dual use was classified using four previously identified groups of health services users: 1) VA-predominant, 2) VA + Medicare visits and labs, 3) VA + Medicare test strips, and 4) VA + Medicare medications.

Key Results

Controlling for Elixhauser comorbidities, dual-use groups 2–4 had significantly decreased odds of death or hospitalization compared to VA-predominant users. Controlling for RxRisk-V comorbidities, groups 2–4 had increased odds of death compared to VA-predominant users, but variable odds of hospitalization, with group 2 having increased odds (OR 1.06, CI 1.04–1.09), while groups 3 (OR 0.96, CI 0.94–0.99) and 4 (OR 0.93, CI 0.89–0.97) had decreased odds.

Conclusions

The method of risk adjustment drastically influences the direction of effect in health outcomes among dual users of VA and Medicare. These findings underscore the need for standardized and reliable risk adjustment methods that are not susceptible to measurement differences across different health systems.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Hynes DM, Koelling K, Stroupe K, et al. Veterans’ access to and use of Medicare and Veterans Affairs health care. Med Care. 2007;45(3):214–23.CrossRefPubMed Hynes DM, Koelling K, Stroupe K, et al. Veterans’ access to and use of Medicare and Veterans Affairs health care. Med Care. 2007;45(3):214–23.CrossRefPubMed
3.
Zurück zum Zitat Humensky J, Carretta H, de Groot K, Brown MM, Tarlov E, Hynes DM. Service utilization of veterans dually eligible for VA and Medicare fee-for-service: 1999-2004. Medicare Medicaid Res Rev. 2012;2(3):mmrr.002.03.a06.CrossRefPubMedCentral Humensky J, Carretta H, de Groot K, Brown MM, Tarlov E, Hynes DM. Service utilization of veterans dually eligible for VA and Medicare fee-for-service: 1999-2004. Medicare Medicaid Res Rev. 2012;2(3):mmrr.002.03.a06.CrossRefPubMedCentral
4.
Zurück zum Zitat Grubaugh AL, Magruder KM, Zinzow HM, Frueh BC. Use of dual health care services among veterans seen in Veterans Affairs primary care clinics. Gen Hosp Psychiatry. 2009;31(6):589–91.CrossRefPubMed Grubaugh AL, Magruder KM, Zinzow HM, Frueh BC. Use of dual health care services among veterans seen in Veterans Affairs primary care clinics. Gen Hosp Psychiatry. 2009;31(6):589–91.CrossRefPubMed
5.
Zurück zum Zitat Ross JS, Keyhani S, Keenan PS, et al. Dual use of Veterans Affairs services and use of recommended ambulatory care. Med Care. 2008;46(3):309–16.CrossRefPubMed Ross JS, Keyhani S, Keenan PS, et al. Dual use of Veterans Affairs services and use of recommended ambulatory care. Med Care. 2008;46(3):309–16.CrossRefPubMed
6.
Zurück zum Zitat Carey K, Montez-Rath ME, Rosen AK, Christiansen CL, Loveland S, Ettner SL. Use of VA and Medicare services by dually eligible veterans with psychiatric problems. Health Serv Res. 2008;43(4):1164–83.CrossRefPubMedPubMedCentral Carey K, Montez-Rath ME, Rosen AK, Christiansen CL, Loveland S, Ettner SL. Use of VA and Medicare services by dually eligible veterans with psychiatric problems. Health Serv Res. 2008;43(4):1164–83.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Trivedi AN, Grebla RC, Jiang L, Yoon J, Mor V, Kizer KW. Duplicate federal payments for dual enrollees in Medicare Advantage plans and the Veterans Affairs health care system. JAMA. 2012;308(1):67–72.CrossRefPubMedPubMedCentral Trivedi AN, Grebla RC, Jiang L, Yoon J, Mor V, Kizer KW. Duplicate federal payments for dual enrollees in Medicare Advantage plans and the Veterans Affairs health care system. JAMA. 2012;308(1):67–72.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Radomski TR, Zhao X, Thorpe CT, et al. VA and Medicare Utilization Among Dually Enrolled Veterans with Type 2 Diabetes: A Latent Class Analysis. J Gen Intern Med. 2016a;31(5):524–31.CrossRefPubMedPubMedCentral Radomski TR, Zhao X, Thorpe CT, et al. VA and Medicare Utilization Among Dually Enrolled Veterans with Type 2 Diabetes: A Latent Class Analysis. J Gen Intern Med. 2016a;31(5):524–31.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Wright SM, Daley J, Fisher ES, Thibault GE. Where do elderly veterans obtain care for acute myocardial infarction: Department of Veterans Affairs or Medicare? Health Serv Res. 1997;31(6):739–54.PubMedPubMedCentral Wright SM, Daley J, Fisher ES, Thibault GE. Where do elderly veterans obtain care for acute myocardial infarction: Department of Veterans Affairs or Medicare? Health Serv Res. 1997;31(6):739–54.PubMedPubMedCentral
12.
Zurück zum Zitat Wolinsky FD, An H, Liu L, Miller TR, Rosenthal GE. Exploring the association of dual use of the VHA and Medicare with mortality: separating the contributions of inpatient and outpatient services. BMC Health Serv Res. 2007;7(1):70.CrossRefPubMedPubMedCentral Wolinsky FD, An H, Liu L, Miller TR, Rosenthal GE. Exploring the association of dual use of the VHA and Medicare with mortality: separating the contributions of inpatient and outpatient services. BMC Health Serv Res. 2007;7(1):70.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Liu CF, Bolkan C, Chan D, Yano EM, Rubenstein LV, Chaney EF. Dual use of VA and non-VA services among primary care patients with depression. J Gen Intern Med. 2009;24(3):305–11.CrossRef Liu CF, Bolkan C, Chan D, Yano EM, Rubenstein LV, Chaney EF. Dual use of VA and non-VA services among primary care patients with depression. J Gen Intern Med. 2009;24(3):305–11.CrossRef
14.
Zurück zum Zitat Shen Y, Findley PA, Maney M, et al. Department of Veterans Affairs-Medicare dual beneficiaries with stroke: where do they get care? J Rehabil Res Dev. 2008;45(1):43–51.CrossRefPubMed Shen Y, Findley PA, Maney M, et al. Department of Veterans Affairs-Medicare dual beneficiaries with stroke: where do they get care? J Rehabil Res Dev. 2008;45(1):43–51.CrossRefPubMed
15.
Zurück zum Zitat Zhu CW, Penrod JD, Ross JS, Dellenbaugh C, Sano M. Use of Medicare and Department of Veterans Affairs health care by veterans with dementia: a longitudinal analysis. J Am Geriatr Soc. 2009;57(10):1908–14.CrossRefPubMedPubMedCentral Zhu CW, Penrod JD, Ross JS, Dellenbaugh C, Sano M. Use of Medicare and Department of Veterans Affairs health care by veterans with dementia: a longitudinal analysis. J Am Geriatr Soc. 2009;57(10):1908–14.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Jia H, Zheng Y, Reker DM, et al. Multiple system utilization and mortality for veterans with stroke. Stroke. 2007;38(2):355–60.CrossRef Jia H, Zheng Y, Reker DM, et al. Multiple system utilization and mortality for veterans with stroke. Stroke. 2007;38(2):355–60.CrossRef
17.
Zurück zum Zitat Wolinsky FD, Miller TR, An H, Brezinski PR, Vaughn TE, Rosenthal GE. Dual use of Medicare and the Veterans Health Administration: are there adverse health outcomes? BMC Health Serv Res. 2006;6(1):131.CrossRefPubMedCentral Wolinsky FD, Miller TR, An H, Brezinski PR, Vaughn TE, Rosenthal GE. Dual use of Medicare and the Veterans Health Administration: are there adverse health outcomes? BMC Health Serv Res. 2006;6(1):131.CrossRefPubMedCentral
18.
Zurück zum Zitat Tarlov E, Lee TA, Weichle TW, et al. Reduced overall and event-free survival among colon cancer patients using dual system care. Cancer Epidem Biomarkers Prev. 2012;21(12):2231–41.CrossRef Tarlov E, Lee TA, Weichle TW, et al. Reduced overall and event-free survival among colon cancer patients using dual system care. Cancer Epidem Biomarkers Prev. 2012;21(12):2231–41.CrossRef
19.
Zurück zum Zitat Helmer D, Sambamoorthi U, Shen Y, et al. Opting out of an integrated healthcare system: dual-system use is associated with poorer glycemic control in veterans with diabetes. Prim Care Diabetes. 2008;2(2):73–80.CrossRef Helmer D, Sambamoorthi U, Shen Y, et al. Opting out of an integrated healthcare system: dual-system use is associated with poorer glycemic control in veterans with diabetes. Prim Care Diabetes. 2008;2(2):73–80.CrossRef
20.
Zurück zum Zitat Wang V, Maciejewski ML, Patel UD, Stechuchak KM, Hynes DM, Weinberger M. Comparison of outcomes for veterans receiving dialysis care from VA and non-VA providers. BMC Health Serv Res. 2013;13(1):26.CrossRefPubMedCentral Wang V, Maciejewski ML, Patel UD, Stechuchak KM, Hynes DM, Weinberger M. Comparison of outcomes for veterans receiving dialysis care from VA and non-VA providers. BMC Health Serv Res. 2013;13(1):26.CrossRefPubMedCentral
21.
Zurück zum Zitat Rosen AK, Gardner J, Montez M, Loveland S, Hendricks A. Dual-system use: are there implications for risk adjustment and quality assessment? Am J Med Qual. 2005;20(4):182–94.CrossRefPubMed Rosen AK, Gardner J, Montez M, Loveland S, Hendricks A. Dual-system use: are there implications for risk adjustment and quality assessment? Am J Med Qual. 2005;20(4):182–94.CrossRefPubMed
22.
Zurück zum Zitat Byrne MM, Kuebeler M, Pietz K, Petersen LA. Effect of using information from only one system for dually eligible health care users. Med Care. 2006;44(8):768–73.CrossRefPubMed Byrne MM, Kuebeler M, Pietz K, Petersen LA. Effect of using information from only one system for dually eligible health care users. Med Care. 2006;44(8):768–73.CrossRefPubMed
23.
Zurück zum Zitat Radomski TR, Fine MJ, Gellad WF. Outcome After Admission at Veterans Affairs vs Non-Veterans Affairs Hospitals. JAMA. 2016b; 316(3): 345–6.CrossRef Radomski TR, Fine MJ, Gellad WF. Outcome After Admission at Veterans Affairs vs Non-Veterans Affairs Hospitals. JAMA. 2016b; 316(3): 345–6.CrossRef
24.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie, CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie, CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.CrossRef
25.
Zurück zum Zitat Elixhauser A, Steiner C, Harris RD, Coffey RM. Comorbidity Measures for Use with Administrative Data. Med Care. 1998;36(1):8–27.CrossRefPubMed Elixhauser A, Steiner C, Harris RD, Coffey RM. Comorbidity Measures for Use with Administrative Data. Med Care. 1998;36(1):8–27.CrossRefPubMed
26.
Zurück zum Zitat Sloan KL, Sales AE, Liu CF, et al. Construction and Characteristics of the RxRisk-V: A VA-Adapted Pharmacy Based Case-mix Instrument. Med Care. 2003;41(6):761–74. Sloan KL, Sales AE, Liu CF, et al. Construction and Characteristics of the RxRisk-V: A VA-Adapted Pharmacy Based Case-mix Instrument. Med Care. 2003;41(6):761–74.
27.
Zurück zum Zitat Johnson ML, El-Serag HB, Tran TT, Hartman C, Richardson P, Abraham NS. Adapting the Rx-Risk-V for Mortality Prediction in Outpatient Populations. Med Care. 2006;44(8):793–97.CrossRefPubMed Johnson ML, El-Serag HB, Tran TT, Hartman C, Richardson P, Abraham NS. Adapting the Rx-Risk-V for Mortality Prediction in Outpatient Populations. Med Care. 2006;44(8):793–97.CrossRefPubMed
28.
Zurück zum Zitat Lu CY, Barratt J, Vitry A, Roughead E. Charlson and Rx-Risk Comorbidity Indices were Predictive of Mortality in the Australian Health Care Setting. J Clin Epidemiol. 2011;64:223–28.CrossRefPubMed Lu CY, Barratt J, Vitry A, Roughead E. Charlson and Rx-Risk Comorbidity Indices were Predictive of Mortality in the Australian Health Care Setting. J Clin Epidemiol. 2011;64:223–28.CrossRefPubMed
29.
Zurück zum Zitat Veterans Access, Choice, and Accountability Act of 2014, Pub. L. no 113–146, 128 Stat 1754 (2014). Print. Veterans Access, Choice, and Accountability Act of 2014, Pub. L. no 113–146, 128 Stat 1754 (2014). Print.
31.
Zurück zum Zitat Gellad WF, Donohue JM, Zhao X, et al. Brand-name prescription drug use among Veterans Affairs and Medicare Part D patients with diabetes: a national cohort comparison. Ann Intern Med. 2013;159(2):105–14.PubMedCentral Gellad WF, Donohue JM, Zhao X, et al. Brand-name prescription drug use among Veterans Affairs and Medicare Part D patients with diabetes: a national cohort comparison. Ann Intern Med. 2013;159(2):105–14.PubMedCentral
32.
Zurück zum Zitat Gellad WF, Zhao X, Thorpe CT, Mor MK, Good CB, Fine MJ. Dual use of Department of Veterans Affairs and Medicare benefits and use of test strips in veterans with type 2 diabetes mellitus. JAMA Intern Med. 2015;175(1):26–34.CrossRefPubMed Gellad WF, Zhao X, Thorpe CT, Mor MK, Good CB, Fine MJ. Dual use of Department of Veterans Affairs and Medicare benefits and use of test strips in veterans with type 2 diabetes mellitus. JAMA Intern Med. 2015;175(1):26–34.CrossRefPubMed
33.
Zurück zum Zitat Gellad WF, Mor M, Zhao X, Donohue J, Good C. Variation in use of high-cost diabetes mellitus medications in the VA healthcare system. Arch Intern Med. 2012;172(20):1608–11.CrossRefPubMed Gellad WF, Mor M, Zhao X, Donohue J, Good C. Variation in use of high-cost diabetes mellitus medications in the VA healthcare system. Arch Intern Med. 2012;172(20):1608–11.CrossRefPubMed
34.
Zurück zum Zitat Thorpe CT, Gellad WF, Good CB, et al. Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia. Diabetes Care. 2015; 38(4):588–95.PubMedPubMedCentral Thorpe CT, Gellad WF, Good CB, et al. Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia. Diabetes Care. 2015; 38(4):588–95.PubMedPubMedCentral
35.
Zurück zum Zitat Durham S, Barosso G, Merriman K, Caldwell D. “How to identify emergency room services in the Medicare claims data,” Research Data Assistance Center, Center for Medicare and Medicaid Services, Technical Publication TN-003, July 2015. https://www.resdac.org/resconnect/articles/144. Last accessed 31 March 2017. Durham S, Barosso G, Merriman K, Caldwell D. “How to identify emergency room services in the Medicare claims data,” Research Data Assistance Center, Center for Medicare and Medicaid Services, Technical Publication TN-003, July 2015. https://​www.​resdac.​org/​resconnect/​articles/​144. Last accessed 31 March 2017.
36.
Zurück zum Zitat Menzin J, Korn JR, Cohen J, et al. Relationship between glycemic control and diabetes-related hospital cost in patients with type 1 or 2 diabetes mellitus. J Manag Care Pharm. 2010;16(4):264–75.PubMed Menzin J, Korn JR, Cohen J, et al. Relationship between glycemic control and diabetes-related hospital cost in patients with type 1 or 2 diabetes mellitus. J Manag Care Pharm. 2010;16(4):264–75.PubMed
38.
Zurück zum Zitat Ajmera M, Wilkins TL, Sambamoorthi U. Dual Medicare and Veteran Health Administration use and ambulatory care sensitive hospitalizations. J Gen Intern Med. 2011;26 Suppl 2:669–75.CrossRefPubMedCentral Ajmera M, Wilkins TL, Sambamoorthi U. Dual Medicare and Veteran Health Administration use and ambulatory care sensitive hospitalizations. J Gen Intern Med. 2011;26 Suppl 2:669–75.CrossRefPubMedCentral
39.
Zurück zum Zitat Shulkin DJ. Beyond the VA Crisis—Becoming a High-Performance Network. N Engl J Med.2016;374:1003–1005.CrossRefPubMed Shulkin DJ. Beyond the VA Crisis—Becoming a High-Performance Network. N Engl J Med.2016;374:1003–1005.CrossRefPubMed
40.
Zurück zum Zitat Khanna G, Narula D, Rao N. The market evolution of provider-led health plans. 2016. McKinsey & Company; Healthcare Systems and Services Practice, New York, NY. Khanna G, Narula D, Rao N. The market evolution of provider-led health plans. 2016. McKinsey & Company; Healthcare Systems and Services Practice, New York, NY.
Metadaten
Titel
The Impact of Medication-Based Risk Adjustment on the Association Between Veteran Health Outcomes and Dual Health System Use
verfasst von
Thomas R. Radomski, MD, MS
Xinhua Zhao, PhD
Carolyn T. Thorpe, PhD, MPH
Joshua M. Thorpe, PhD, MPH
Jennifer G. Naples, PharmD
Maria K. Mor, PhD
Chester B. Good, MD, MPH
Michael J. Fine, MD, MSc
Walid F. Gellad, MD, MPH
Publikationsdatum
01.05.2017
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 9/2017
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-017-4064-4

Weitere Artikel der Ausgabe 9/2017

Journal of General Internal Medicine 9/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.